https://doi.org/10.55788/99e94170
The scarcity of adequate health professionals and the strain on primary care systems necessitate general practitioners to engage in skin cancer screening. However, their limited dermoscopy skills highlight the need for essential training. "We evaluated the impact of training sessions on the diagnostic accuracy and therapeutic strategies proposed by general practitioners in the treatment of skin cancer," explained Dr Christian Dorado Cortez (University Hospital of Saint-Etienne, France) [1].
The study consisted of 2 training sessions: the first employing the dermoscopy 2-step algorithm and the second incorporating the 2-step algorithm augmented by AI software. The 2-step algorithm consists of 2 levels. First, the observer must decide whether a lesion is of melanocytic or non-melanocytic origin. When the lesion is identified to be of melanocytic origin, step 2 entails the identification of the melanocytic lesion as benign, suspect, or malignant [2].
The participants were general practitioners from 2 universities, who completed 3 online tests before and after each training session. Additionally, they underwent a final evaluation a month after their second training session. Each online test comprised 51 cases, assessing diagnostic accuracy, lesion characterisation, the capability to recommend therapeutic strategies, and their confidence level for each case.
The mean score of the initial test, conducted before any training, was 4.71 out of 51 (n=41). Subsequently, significant improvements in the second test were seen to 6.72 (following the first training session) and 25.6 (following the second training session; P<0.001). The results from the fourth test demonstrated a notably persistent improvement in the average score, particularly when utilising AI analysis (mean score 27.18 out of 51).
“The study results confirmed that dermoscopy training combined with AI considerably improves the diagnostic accuracy, the ability of general practitioners to determine the nature of the lesion, and the management of pigmented lesions,” Dr Dorado Cortez concluded.
"We strongly encourage universities to offer dermoscopy training to all general practitioners," he emphasised. Such training initiatives could substantially enhance skin cancer screening in primary care, ultimately improving overall skin cancer survival rates.
- Dorado Cortez C, et al. Assessment of the impact of a dermoscopy training associated with an artificial intelligence on general practitioner residents. P1417, EADV Congress 2023, 11–14 October, Berlin, Germany.
- Argenziano G, et al. J Am Acad Dermatol 2003;48:679–693.
Copyright ©2023 Medicom Medical Publishers
Posted on
Previous Article
« Dit is een proefdocument Next Article
Improved AI tool shows high sensitivity rates in skin cancer detection »
« Dit is een proefdocument Next Article
Improved AI tool shows high sensitivity rates in skin cancer detection »
Table of Contents: EADV 2023
Featured articles
Tapinarof on course to become a new topical treatment in AD
AD and Eczema in 2023
Tapinarof on course to become a new topical treatment in AD
Upadacitinib provides sustained skin clearance in adolescents and adults with AD
Sustained deep clinical and itch responses with novel IL-13 inhibitor
IL-13 inhibitor shows potential in atopic dermatitis
Encouraging results for amlitelimab in atopic dermatitis
Chronic hand eczema: patients share similar molecular signatures regardless of AD status
Severe hand eczema: dupilumab could be a future treatment
Psoriasis News
Dual IL-17 blockade yields efficacy on joints and skin
High-dose subcutaneous spesolimab prevents GPP flares up to week 48
Drug survival of guselkumab and risankizumab seems superior to other biologics
IL-23 blockers may lower the risk of developing inflammatory and psoriatic arthritis
First-in-class oral IL-23 inhibitor safe and effective for moderate-to-severe plaque psoriasis
Hidradenitis Suppurativa: End of the Diagnostic and Therapeutic Draught
Skin tape stripping allows a novel precision medicine approach in HS
Nanobodies: A novel way to treat HS
Anti-IL17 blockade leads to maintained pain reduction in patients with HS
Vitiligo: Novel Treatment Options
JAK1 inhibition: a promising forthcoming treatment option in vitiligo
Vitiligo: Continuation of topical ruxolitinib successful in many initial non-responders
Alopecia Areata: Novel Developments
JAK3/TEC inhibition achieves clinically meaningful responses in AA
Alopecia areata: remarkable regrowth rates with deuruxolitinib
Botanical drug solution improves hair regrowth in children and adolescents with AA
What’s New in Other Disease Entities
Nemolizumab shows high success rates in prurigo nodularis
Remibrutinib reduces itch, sleep problems, and activity impairment in patients with CSU
Innovative wound gel reduces frequency of painful dressing changes in epidermolysis bullosa
Best of the Posters
Women with psoriasis face increased adverse effects with systemic therapy
Improved AI tool shows high sensitivity rates in skin cancer detection
Dermoscopy training combined with AI significantly improves skin cancer detection
Related Articles
October 6, 2021
Keratinocyte carcinoma incidence and mortality on the rise
© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy
HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com